|
Home / Articles
/ Hormones
/ Hungry, Hungry Hormones - Part
II
Hungry, Hungry Hormones - Part II
An overview of Leptin and related hormones
By Dr. John M Berardi, Ph.D.
First published at www.t-mag.com, May 9 2003.
Printer
friendly version
Express Yourself
As discussed last weekin Part
I, Leptin is a hormone produced when the OB (obesity) gene is expressed.
While I've already discussed one mechanism to induce OB gene expression
and Leptin production, the three main cellular signals involved are:
• Increased energy/carbohydrate flux through the HBP.
• Increased triacylglycerol (triglyceride) metabolites. These
include diacylglycerols and/or free fatty acids.
• Increased tension in adipose tissue due to cellular stretching
(increases in adipose size).
As you can see, these three phenomena provide response mechanisms
whereby both acute and chronic overfeeding or underfeeding will influence
OB gene expression and Leptin production. If overfeeding, more carbohydrates
will flux through HBP, more triglycerides will be metabolized, and adipose
tissue sizes will increase. This leads to more Leptin production. Conversely,
if underfeeding, carbohydrate and triglyceride availability will be
decreased, as will adipose tissue size. Of course, this means less Leptin.
Since we now know why Leptin is formed, how about discussing where
it's formed? In adult humans, most of the body's leptin is formed in
white adipose tissue. This should be self-evident from the signals discussed
above. However, Leptin has also been found in the following tissues,
making it relatively ubiquitous.
• Brown adipose tissue
• Gastric epithelium
• Placenta
• Skeletal muscle
• Mammary glands
Of Rat and Fat
When Leptin was originally discovered, scientists found that rats
that had mutations in the OB gene (and couldn't produce Leptin) became
insanely obese. Now when I say obese, I'm not talking a little overweight
here. I'm talking so obese that members of NAAFA actually pointed and
laughed. In the obese rats, the extreme obesity was caused by mutations
in the Ob gene. In these animals, there was simply too little Leptin.
Interestingly, when administered Leptin, these tubby rats saw big increases
in metabolic rate and lost massive amounts of body fat.
As a result of these findings, researchers speculated that Leptin
might be a magical fat loss hormone. Unfortunately for the pharmaceutical
companies who immediately jumped all over the rights to sell recombinant
Leptin, this hypothesis didn't pan out. You see, another model of rat
was discovered, a model that was as obese as the Leptin deficient rats
but had adequate Leptin concentrations in the blood. These rats, instead
of a Leptin deficiency, had problems with their Leptin receptor. Therefore
the Leptin that was present couldn't do its job.
In addition to this new rodent data, thwarting the potential billions
to be gained from Leptin sales, new human data also showed that Leptin
was unlikely to help the obese drop those few hundred unwanted pounds.
Research had clearly demonstrated that:
a) Very few obese humans actually suffer from Ob gene mutations
b) Very few obese humans actually suffer from Leptin receptor mutations
c) Obese humans often have very high concentrations of leptin in the
plasma
Since obese humans often have so much Leptin, research has been directed
toward how these individuals can have so much Leptin, yet fail to respond
with a reduction in body weight, as did our furry rodent friends. One
hypothesis that has gained popularity suggests that a Leptin resistance
causes human obesity. In other words, the very obese got this way because
they were somehow intolerant to rising Leptin. As one researcher put
it, "Leptin resistance is not well defined, however this term is
usually used to mean that leptin does not perform its central and peripheral
functions."
At this point, there is some evidence for the Leptin resistance hypothesis.
Since Leptin seems to have central effects, the saturable blood brain
barrier transport system for leptin may be linked to obesity. Since
obese humans have a CSF (cerebrospinal fluid) to plasma ratio that is
much lower than normal-sized humans, it appears that only so much Leptin
can get across the BBB into the brain. In addition, in rats, dietary
induced obesity (DIO) is accompanied by high plasma leptin concentrations.
This leptin doesn't seem to prevent the obesity. However, when administered
intracerebroventricular leptin (leptin into the brain), they lose weight,
indicating a potential BBB transport limit.
Although these data offer support to the idea that there is a limit
to amount of leptin allowed into the brain and therefore a type of Leptin
"resistance" exists at the higher levels of Leptin production,
some authors believe that leptin resistance is actually a misnomer.
These researchers are of the opinion that since leptin may not be designed
to function in such high concentrations as seen in obesity, Leptin may
be more important in its absence than its presence (i.e. may be more
important in calorie restriction and not in calorie excess, as is often
seen with obesity). In other words, it's not that the obese are "improperly"
responding to their leptin. Instead, these authors are suggesting that
the obese aren't "supposed" to have so much leptin and therefore
don't respond to it's elevation above a certain point.
What's Leptin Do?
The hormone Leptin seems to affect nearly every system of the body.
Since there are Leptin receptors in the brain and throughout the body,
we can discuss the effects of Leptin as central or peripheral.
Since Leptin is released (mostly) by adipose tissues, adipose tissue
seems to be a peripheral static indicator of the chronic energy balance
of the body. Once released into the blood, under normal conditions,
Leptin travels across the blood brain barrier and is sensed by the Leptin
receptors in the hypothalamus. Since these receptors have some idea
of what's a "normal" Leptin signal, changes in Leptin binding
initiates the release of a series of anabolic (orexigenic or meal stimulating)
and catabolic (anorexigenic or meal preventing) hormones/neurotransmitters.
An increase in leptin leads to the expression of several anorexigenic
(catabolic) hormones and neurotransmitters including áMSH and
CART. These chemicals decrease hunger and meal size.
Conversely, a decrease in leptin leads to the expression of several
orexigenic (anabolic) hormones and neurotransmitters including NPY and
AgRP. These compounds increase hunger and meal size. This is a rather
nice way for the body to deal with energy surplus or energy deficit.
If there's a surplus, Leptin increases, signaling the hypothalamus to
tell the body to stop eating. Conversely, if there's a deficit, Leptin
decreases, signaling the hypothalamus to make us really hungry. For
you visual learners, here's a visual depiction of what happens when
Leptin concentrations increase in the hypothalamus.

Although I only mentioned a couple key orexigenic and anorexigenic
hormones/neurotransmitters, there are many others that can interact
with Leptin or the same signaling systems as Leptin. These are listed
below:
| Orexigenic (stimulate food intake) —
May act in the lateral hypothalamic neurons |
Anorexigenic (reduce food intake) —May
act on the ventral & dorsal medial hypothalamus |
|
Neuropeptide Y (NPY)— is the most potent orexiant known;
may respond to aberrant leptin signaling; antagonism may reduce
hunger and fat mass
Agouti Related Peptide (AgRP) — potent orexiant; may respond
to absent leptin; antagonism may reduce hunger and fat mass
Melanin Concentrating Hormone (MCH) — receives signals
from NPY to increase food intake
Orexin — increases arousal and food intake
Ghrelin — a potent GH releasing hormone released from the
stomach, pituitary, and hypothalamus; increases food intake and
body weight; may compete with leptin |
Pro-Opiomelanocortin (POMC) — precursor to áMSH
Melanocyte Stimulating Hormone (áMSH) — decreases
food intake; may respond to increased leptin; antagonism increases
appetite and food
Melanocortin 4 receptor (MC4R) — áMSH receptor;
binding of agonist reduces food intake
Cocaine Amphetamine Related Transcript (CART) — decreases
food intake; may respond to increased leptin
CCK — gastric released peptide; increases satiety; reduces
food intake (single feeding and meal frequency)
Corticotropin releasing factor (CRF) — regulates adrenal
hormones and ACTH; decreases food intake, increases energy expenditure
Insulin — increasing concentrations of insulin decrease
appetite
|
While these energy regulating hormones and neurotransmitters may be
relatively new to you, the important message here is that they are responsible
for sensing a starvation response (with decreased Leptin). In response
to these decreases in Leptin concentrations, these chemicals are responsible
for promoting the following effects:
a. Increased food intake
b. Decreased skeletal muscle growth
c. Decreased energy expenditure
d. Decreased body temperature
e. Decreased reproductive function
f. Increased adrenal production of stress hormones
g. Increased parasympathetic tone
Conversely, these energy regulating hormones and neurotransmitters
are responsible for sensing an energy surplus (with increased Leptin).
Therefore, when Leptin concentrations increase, the following effects
are promoted:
a. Decreased food intake
b. Increased energy expenditure
c. Increased sympathetic tone
Again, for you visual kids, here's a schematic. Remember, Leptin is
regulated in response to acute feeding as well as chronic energy balance
(as measured by adipose mass). Therefore, while you'll see weight gain
and weight loss as regulators below, you could replace these terms with
underfeeding and overfeeding.

Notice that the main discussion today has centered on the central
effects of Leptin (in the hypothalamus). However, Leptin, as discussed
earlier, also has a number of peripheral effects. The peripheral effects
include the following.
• In skeletal muscle, leptin increases fat oxidation and insulin
sensitivity, explaining part of its effect on weight reduction.
• Leptin may act in concert with the immune system since leptin
deficient animals have reduced immunity. This may explain part of
the effect of dieting on weakened immune function.
• Leptin may play a permissive role in female menarche since
there is an inverse relationship between Leptin concentrations and
age of first menstruation. This means girls with more body fat (and
higher Leptin concentrations) may have first menstruation sooner than
leaner girls.
• Leptin concentrations and Testosterone concentrations are
inversely proportional through the normal range of Testosterone. This
means that as Leptin goes up, Testosterone down. Conversely, as Leptin
goes down, Testosterone goes up. This should be no surprise as very
overweight men are often hypogonadal. However, you should wonder why
those who are extremely lean are often hypogonadal as well.
• The paradox of this relationship is that leptin is partly
responsible for increasing GnRH secretion as well as LH, FSH, and
Testosterone secretion. Therefore, at very low concentrations there
would be an occurrence of hypogonadism. But very high concentrations,
Leptin directly inhibits Testosterone release (leptin decreases T
secretion from testis, even in spite of increased GnRH activity),
again causing hypogonadism. Therefore the best Leptin concentrations
would be at the low normal range. Not coincidentally, this usually
occurs in those lean individuals who are well fed.
In addition to these peripheral effects, Leptin has shown the following
interactions with other hormones:
• Leptin increases GnRH at hypothalamus
• Leptin decreases Testosterone at testis
• Glucocorticoids increase plasma leptin
• SNS activity (epinephrine) decreases plasma leptin
• Testosterone decreases plasma leptin
• Insulin acts with leptin by stimulating the same neuronal
populations
• Insulin increases Ob gene expression
• Ghrelin competes with leptin centrally, with opposite actions
as leptin
• Leptin and insulin sensitize the hindbrain to the anorexigenic
hormone CCK
The following adipocytokines (hormones released from adipose) may
also interact with leptin:
- Resistin
- adipocytokine that may regulate insulin sensitivity
- Adiponectin
- enhances insulin function
- increases with insulin and decreases with obesity
- increases UCP2 in muscle
- increases fatty acid transporter protein
- increases acyl CoA oxidase
- decreases triglyceride content in liver and muscle
- Adipsin
- is found in proportion to adiposity
- is required for the synthesis of ASP (acylation stimulating
protein — is involved in the uptake and esterification of
TAG and FA)
- stimulates TAG synthesis more than insulin
What's that sound? Oh, that's the bell! Quickly I'd like to recap
this week's lesson. First of all, Leptin is released from many peripheral
tissues but the biggest player is white adipose. Once released, Leptin
has all kinds of divergent effects on the peripheral systems of the
body, many of which are just coming to light. These peripheral effects
include interactions with many hormones of the body as well as interactions
with the skeletal muscle, the immune system, and the reproductive system.
Also, Leptin acts centrally in order to stir up a neurotransmitter soup
of meal stimulating and meal reducing chemicals. These central and peripheral
effects are important to understand as they are ultimately responsible
for metabolic changes with feeding as well as weight gain and loss.
So class is now dismissed for this week. But don't miss out on next
week's lecture. I'll be reviewing some of the important feeding studies
and discussing some recent data showing how recombinant Leptin injections
may actually help prevent the metabolic decline associated with dieting.
|